Semnur Pharmaceuticals, Inc. (SMNR)

Semnur Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	0.09	0.01	0.01	0.03
Cash & Short-Term Investments	0.09	0.01	0.01	0.03
Cash Growth	-	-	-57.14%	-
Prepaid Expenses	-	0	0	0.05
Other Current Assets	-	5.98	-	-
Total Current Assets	0.09	6	0.01	0.07
Property, Plant & Equipment	0.69	0.69	0.69	0.69
Total Assets	0.77	6.68	0.7	0.76
Accrued Expenses	1.27	0.04	0.9	0.17
Other Current Liabilities	-	-	-	0.02
Total Current Liabilities	10.03	0.04	0.9	0.2
Long-Term Debt	5.34	49.43	37.9	35.4
Total Liabilities	15.37	49.47	38.8	35.6
Common Stock	0.02	0	0	0
Additional Paid-In Capital	255.03	72.6	72.6	72.6
Retained Earnings	-269.64	-115.38	-110.69	-107.43
Shareholders' Equity	-14.59	-42.78	-38.09	-34.83
Total Liabilities & Equity	0.77	6.68	0.7	0.76
Total Debt	9.81	49.43	37.9	35.4
Net Cash (Debt)	-9.73	-49.42	-37.89	-35.37
Net Cash Per Share	-0.06	-0.31	-0.24	-0.22
Filing Date Shares Outstanding	229.74	160	160	160
Total Common Shares Outstanding	229.74	160	160	160
Working Capital	-9.95	5.96	-0.88	-0.12
Book Value Per Share	-0.06	-0.27	-0.24	-0.22
Tangible Book Value	-14.59	-42.78	-38.09	-34.83
Tangible Book Value Per Share	-0.06	-0.27	-0.24	-0.22
Machinery	0.03	0.03	0.03	0.03
Construction In Progress	0.69	0.69	0.69	0.69

Source: S&P Global Market Intelligence. Standard template. Financial Sources.